• Med BioGene Inc., of Vancouver, British Columbia, reported a nonbrokered private placement of a maximum of $300,000 of units. Each unit will be issued at a price of 5 cents and will consist of one common share and one-half of one common share purchase warrant. Each whole common share purchase warrant will entitle the holder to purchase one common share at a price of 10 cents for a period of 24 months, subject to the acceleration by MBI of the expiration of the warrants if the closing price of the common shares on the TSX Venture Exchange is greater than 25 cents for 20 or more consecutive trading days. MBI said it will use the proceeds for general corporate purposes. The company's shares (TSX V:MBI) closed flat Friday at C6 cents.